Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

Xspray's Dasynoc approval bid foiled again by FDA's manufacturer concerns - Fierce Pharma

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA approves Ultragenyx gene therapy - STAT

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine - Pharmaceutical Commerce

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

BBP: The Biotech ETF That Filters For FDA-Approved Drugs (NYSEARCA:BBP) - Seeking Alpha

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Trump taps White House aide Heidi Overton to lead FDA - pharmaphorum

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Earnings call transcript: Ascelia Pharma rises 8.2% after FDA setback in Q2 2027 - Investing.com

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Lundbeck CEO on FDA criticism: “The matter is closed” - medwatch.com

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Ultragenyx’ Genglycos wins FDA accelerated approval - The Pharma Letter

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection - STAT

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

White House aide nominated for FDA commissioner role - The Pharma Letter

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Ultragenyx, after FDA speed bump, lands 1st gene therapy nod with green light in glycogen storage disease - Fierce Pharma

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Celcuity keeps cool amid questions about Revtorpyk launch timing - Fierce Pharma

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Regeneron's Pasatru scores FDA approval in ultra-rare bone lesions disorder - Fierce Pharma

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Glenmark Pharma Gets US FDA Approval For Fluticasone Nasal Spray In $295 Million Market - Sahi

news.google.com · 21 Aug 2026

Google News – FDA (biotech/pharma) External News

Strides Pharma shares jump 7.5% after US FDA clears Bengaluru facility - Moneycontrol.com

news.google.com · 21 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Xspray's Dasynoc approval bid foiled again by FDA's manufacturer concerns - Fierce Pharma

FDA approves Ultragenyx gene therapy - STAT

Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine - Pharmaceutical Commerce

BBP: The Biotech ETF That Filters For FDA-Approved Drugs (NYSEARCA:BBP) - Seeking Alpha

Trump taps White House aide Heidi Overton to lead FDA - pharmaphorum

Earnings call transcript: Ascelia Pharma rises 8.2% after FDA setback in Q2 2027 - Investing.com

Lundbeck CEO on FDA criticism: “The matter is closed” - medwatch.com

Ultragenyx’ Genglycos wins FDA accelerated approval - The Pharma Letter

Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection - STAT

White House aide nominated for FDA commissioner role - The Pharma Letter

Ultragenyx, after FDA speed bump, lands 1st gene therapy nod with green light in glycogen storage disease - Fierce Pharma

Celcuity keeps cool amid questions about Revtorpyk launch timing - Fierce Pharma

Regeneron's Pasatru scores FDA approval in ultra-rare bone lesions disorder - Fierce Pharma

Glenmark Pharma Gets US FDA Approval For Fluticasone Nasal Spray In $295 Million Market - Sahi

Strides Pharma shares jump 7.5% after US FDA clears Bengaluru facility - Moneycontrol.com